EBR Systems' WiSE device reduces QRS duration by 26% in 100-patient US study
EBR•EBR Systems reported a 26% reduction in QRS duration with its WiSE system in a 100-patient study across 31 US centers. Results were presented at the Asia Pacific Heart Rhythm Society Scientific Sessions in Busan, Korea, on October 21-24, 2026.
1. Study findings
EBR Systems reported improved ventricular electrical synchronization with its WiSE system in 100 patients across 31 US centers. No patient showed worsening electrical activation time, and outcomes were similar across two electrode locations.
2. Results presented
The results were presented at the Asia Pacific Heart Rhythm Society Scientific Sessions, held October 21-24, 2026, in Busan, Korea.
